Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1774d173c8c29d3353a720e21634a41a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
filingDate |
1994-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72cecb54114714411dd2817d66cd2bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_593a3e1175100b3777a4e3643c8ae7d1 |
publicationDate |
2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2176145-C |
titleOfInvention |
Biocompatible ocular implants |
abstract |
Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration. |
priorityDate |
1993-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |